C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer

C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer

Biomarkers for predicting response to anti-programmed death-1 (PD-1) immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) remain in demand. Since anti-tumor immune activation is a process, early dynamic changes of the acute-phase reactant C reactive protein (CRP) may serve as a pre...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefan Diem, Markus Joerger, Fiamma Berner, Lukas Flatz, Niklas Klümper, Manuel Ritter, Michael Hölzel, Jörg Ellinger, Peter Brossart, Annkristin Heine, Jonas Saal, Christa Lichtensteiger, Nina Wyss, Franz Georg Bauernfeind, Sabine Schmid, Martin Frueh, Tobias Bald
Format: Article
Language:English
Published: BMJ Publishing Group 2022-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/3/e004024.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/10/3/e004024.full

Similar Items